RA Capital Management - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$13,858,000
-28.5%
677,663
-47.6%
1.96%
-1.9%
Q3 2016$19,394,000
+38.6%
1,292,9400.0%2.00%
+3.3%
Q2 2016$13,990,000
-20.2%
1,292,9400.0%1.94%
-13.6%
Q1 2016$17,532,000
+20.3%
1,292,940
+63.6%
2.24%
+55.3%
Q4 2015$14,579,000
-27.1%
790,2000.0%1.44%
-49.8%
Q3 2015$20,008,000790,2002.87%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders